Income Statement Alpa Laboratories Limited

Stocks

ALPA

INE385I01010

Pharmaceuticals

Market Closed - NSE India S.E. 08:23:44 2026-09-25 EDT			5-day change	1st Jan Change
59.10 ^INR	+0.05%		-0.42%	-23.93%

09-17	Alpa Laboratories Limited Announces Appointment of Diksha Jaswani as Company Secretary Cum Compliance Officer, Effective September 17, 2026	CI
08-13	Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

f23e529590b5.y856YruSbfKPTO9IucFLRt9TjqiA2btLwXho0GMtZ7s.soMTPYqjNYrfHZkh_6AJBa1q1OP5mtEP9VUNs1MYDtC-lCpTgqQHsNgEqg

Published financial data: ALPA LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Revenues	1.12B	930M	1.09B	1.12B	1.06B
Other Revenues, Total	108M	-	-	-	-
Total Revenues	1.23B	930M	1.09B	1.12B	1.06B
Cost of Goods Sold, Total	761M	617M	747M	760M	743M
Gross Profit	469M	313M	341M	364M	315M
Selling General & Admin Expenses, Total	123M	125M	156M	150M	164M
Provision for Bad Debts	-	-	-	-	-
Depreciation & Amortization - (IS)	16.57M	13.29M	19.55M	22.02M	20.92M
Other Operating Expenses	132M	107M	98.37M	168M	118M
Other Operating Expenses, Total	272M	245M	274M	339M	303M
Operating Income	198M	67.62M	66.58M	25.01M	11.98M
Interest Expense, Total	-1.07M	-825K	-3.23M	-2.32M	-88K
Interest And Investment Income	-	12.3M	25.63M	24.11M	27.09M
Net Interest Expenses	-1.07M	11.48M	22.41M	21.79M	27M
Income (Loss) On Equity Invest.	-	-2K	-	-	-
Currency Exchange Gains (Loss)	-	19.56M	7.39M	8.56M	1.29M
Other Non Operating Income (Expenses)	-1.12M	60.42M	20.1M	3.02M	7.06M
EBT, Excl. Unusual Items	196M	159M	116M	58.39M	47.33M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-14K	-158K	90.34M	198M	120M
Gain (Loss) On Sale Of Assets	-	-	-	504K	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	196M	159M	207M	257M	167M
Income Tax Expense	54.7M	33.08M	39.06M	61.64M	16.87M
Earnings From Continuing Operations	141M	126M	168M	195M	150M
Net Income to Company	141M	126M	168M	195M	150M
Net Income - (IS)	141M	126M	168M	195M	150M
Net Income to Common Incl Extra Items	141M	126M	168M	195M	150M
Net Income to Common Excl. Extra Items	141M	126M	168M	195M	150M
Per Share Items
Net EPS - Basic	6.7	5.98	7.97	9.27	7.13
Basic EPS - Continuing Operations	6.7	5.98	7.97	9.27	7.13
Basic Weighted Average Shares Outstanding	21.04M	21.04M	21.04M	21.04M	21.04M
Net EPS - Diluted	6.7	5.98	7.97	9.27	7.13
Diluted EPS - Continuing Operations	6.7	5.98	7.97	9.27	7.13
Diluted Weighted Average Shares Outstanding	21.04M	21.04M	21.04M	21.04M	21.04M
Normalized Basic EPS	5.81	4.72	3.46	1.73	1.41
Normalized Diluted EPS	5.81	4.72	3.46	1.73	1.41
Supplemental Items
EBITDA	214M	80.91M	86.13M	47.03M	32.9M
EBITA	198M	67.82M	66.81M	25.12M	11.98M
EBIT	198M	67.62M	66.58M	25.01M	11.98M
EBITDAR	215M	81.53M	86.84M	47.85M	35.01M
Total Revenues (As Reported)	1.23B	1.02B	1.24B	1.36B	1.22B
Effective Tax Rate - (Ratio)	27.96	20.81	18.88	24.01	10.11
Total Current Taxes	31M	35.96M	30M	40.64M	30M
Total Deferred Taxes	23.55M	-2.88M	1.13M	20.98M	-11.57M
Normalized Net Income	122M	99.41M	72.8M	36.49M	29.58M
Interest on Long-Term Debt	1.05M	822K	920K	607K	415K
Supplemental Operating Expense Items
Advertising Expense	2.77M	3.11M	22.53M	4.88M	4.1M
Selling and Marketing Expenses	2.77M	3.11M	22.53M	4.88M	4.1M
Net Rental Expense, Total	702K	626K	712K	817K	2.11M
Imputed Operating Lease Interest Expense	199K	101K	487K	574K	117K
Imputed Operating Lease Depreciation	503K	525K	225K	243K	1.99M
Maintenance & Repair Expenses, Total	22.75M	20.98M	24M	16.03M	28.06M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Assets
Cash And Equivalents	15.75M	88.14M	17.1M	22.22M	28.49M
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	687M	720M	911M	1.1B	1.35B
Total Cash And Short Term Investments	703M	808M	929M	1.13B	1.38B
Accounts Receivable, Total	380M	467M	412M	468M	408M
Other Receivables	46.71M	29.84M	19.42M	46.34M	48.3M
Notes Receivable	5.36M	5.62M	5.71M	5.37M	5.3M
Total Receivables	432M	503M	437M	520M	462M
Inventory	155M	126M	137M	176M	133M
Prepaid Expenses	2.55M	2.53M	3.12M	2.57M	2.81M
Other Current Assets, Total	97.05M	51.13M	105M	98.75M	132M
Total Current Assets	1.39B	1.49B	1.61B	1.92B	2.11B
Gross Property Plant And Equipment	343M	333M	-	511M	520M
Accumulated Depreciation	-251M	-264M	-	-305M	-319M
Net Property Plant And Equipment	92.16M	69.59M	114M	206M	201M
Long-term Investments	65.4M	77.66M	82.71M	87.71M	80.21M
Goodwill	-	-	-	-	-
Other Intangibles, Total	1.04M	834K	601K	483K	363K
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	4.37M	33.33M	16.44M	7.16M	30.71M
Total Assets	1.55B	1.67B	1.82B	2.23B	2.42B
Liabilities
Accounts Payable, Total	149M	151M	118M	187M	178M
Accrued Expenses, Total	12.17M	12.89M	22.16M	42.21M	20.33M
Short-term Borrowings	23.44M	-	44.58M	343K	25.08M
Current Portion of Long-Term Debt	13.78M	15.27M	7.88M	-	-
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	59.96M	79.87M	-	-	-
Deferred Tax Liability Current	25.71M	22.83M	-	-	-
Other Current Liabilities	29.54M	37.72M	88.27M	238M	302M
Total Current Liabilities	314M	319M	281M	467M	525M
Long-Term Debt	21.25M	7.77M	-	-	-
Unearned Revenue Non Current	-	-	-	-	-
Deferred Tax Liability Non Current	-	-	23.96M	44.93M	33.36M
Other Non Current Liabilities	-2K	-	-1K	-	-
Total Liabilities	335M	327M	305M	512M	559M
Common Stock, Total	210M	210M	210M	210M	210M
Additional Paid In Capital	550M	550M	550M	550M	550M
Retained Earnings	457M	586M	759M	954M	1.1B
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	1.22B	1.35B	1.52B	1.71B	1.86B
Total Equity	1.22B	1.35B	1.52B	1.71B	1.86B
Total Liabilities And Equity	1.55B	1.67B	1.82B	2.23B	2.42B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	21.04M	21.04M	21.04M	21.04M	21.04M
ECS Total Common Shares Outstanding	21.04M	21.04M	21.04M	21.04M	21.04M
Book Value / Share	57.86	63.96	72.2	81.48	88.53
Tangible Book Value	1.22B	1.34B	1.52B	1.71B	1.86B
Tangible Book Value Per Share	57.81	63.92	72.17	81.45	88.52
Total Debt	58.47M	23.04M	52.46M	343K	25.08M
Net Debt	-644M	-785M	-876M	-1.13B	-1.35B
Debt Equivalent Oper. Leases	5.62M	5.01M	5.7M	6.54M	16.86M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	95.85M	80.33M	84.16M	109M	95.72M
Inventories - Work In Process, Total	9M	8.77M	27.55M	27.55M	12.81M
Inventories - Finished Goods, Total	49.78M	37.31M	24.95M	39.47M	24.8M
Inventories - Others	-	-	-	-	-
Land - (BS)	1.34M	1.34M	-	85.95M	86.93M
Buildings, Total	50.27M	50.27M	-	69.44M	63.06M
Machinery, Total	274M	264M	-	338M	341M
Full Time Employees	393	318	410	453	457

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Net Income	141M	126M	168M	195M	150M
Depreciation & Amortization - CF	16.48M	13.08M	19.32M	21.91M	20.92M
Amortization of Goodwill and Intangible Assets - (CF)	123K	209K	234K	117K	-
Depreciation & Amortization, Total	16.6M	13.29M	19.55M	22.02M	20.92M
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-88.5M	-33M	-100M	-165M	-120M
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-100K	2K	-	-	-
Provision and Write-off of Bad Debts	5.4M	6M	4.06M	8.53M	5.2M
Other Operating Activities, Total	5.88M	-15.04M	-13.84M	-630K	-37.25M
Change In Accounts Receivable	-300K	-66.41M	52.52M	-75.89M	56.04M
Change In Inventories	11M	28.22M	-10.24M	-39.74M	43.07M
Change In Accounts Payable	-78.9M	19.81M	-37.07M	204M	-9.03M
Change in Other Net Operating Assets	9.7M	10.35M	-45.79M	34.51M	-16.53M
Cash from Operations	21.7M	89.04M	36.49M	183M	92.87M
Capital Expenditure	-21.9M	-11.26M	-63.85M	-114M	-32.44M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-100K	-4.96M	-	-	-
Sale (Purchase) of Real Estate properties	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-149M	-286K	-95.14M	-33.94M	-103M
Other Investing Activities, Total	15.3M	37.78M	25.63M	24.11M	27.09M
Cash from Investing	-156M	21.28M	-133M	-124M	-109M
Short Term Debt Issued, Total	35.4M	-	37.2M	-	24.74M
Long-Term Debt Issued, Total	21.2M	-	-	-	65K
Total Debt Issued	56.6M	-	37.2M	-	24.8M
Short Term Debt Repaid, Total	-	-263K	-	-52.12M	-
Long-Term Debt Repaid, Total	-	-35.43M	-7.77M	-	-
Total Debt Repaid	-	-35.7M	-7.77M	-52.12M	-
Other Financing Activities, Total	-2.2M	-2.24M	-3.59M	-2.32M	-2.58M
Cash from Financing	54.4M	-37.93M	25.83M	-54.44M	22.22M
Miscellaneous Cash Flow Adjustments	-100K	-	-	-	-
Net Change in Cash	-80.1M	72.39M	-71.04M	5.12M	6.26M
Supplemental Items
Cash Interest Paid	2.2M	2.24M	3.59M	2.32M	2.58M
Cash Income Tax Paid (Refund)	35.7M	35.96M	36.41M	40.69M	28.44M
Levered Free Cash Flow	168M	65.56M	-56M	44.48M	96.99M
Unlevered Free Cash Flow	169M	66.07M	-53.98M	45.92M	97.04M
Change In Net Working Capital	-50.48M	-21.78M	51.29M	-122M	-101M
Net Debt Issued / Repaid	56.6M	-35.7M	29.42M	-52.12M	24.8M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Profitability
Return on Assets	8.37	2.62	2.38	0.77	0.32
Return on Total Capital	10.5	3.2	2.83	0.95	0.41
Return On Equity %	12.29	9.82	11.71	12.06	8.38
Return on Common Equity	12.29	9.82	11.71	12.06	8.38
Margin Analysis
Gross Profit Margin %	38.15	33.66	31.33	32.38	29.78
SG&A Margin	9.98	13.5	14.36	13.3	15.53
EBITDA Margin %	17.43	8.7	7.92	4.18	3.11
EBITA Margin %	16.09	7.3	6.14	2.23	1.13
EBIT Margin %	16.08	7.27	6.12	2.22	1.13
Income From Continuing Operations Margin %	11.45	13.54	15.43	17.34	14.19
Net Income Margin %	11.45	13.54	15.43	17.34	14.19
Net Avail. For Common Margin %	11.45	13.54	15.43	17.34	14.19
Normalized Net Income Margin	9.94	10.69	6.69	3.25	2.8
Levered Free Cash Flow Margin	13.67	7.05	-5.15	3.96	9.17
Unlevered Free Cash Flow Margin	13.72	7.11	-4.96	4.08	9.17
Asset Turnover
Asset Turnover	0.83	0.58	0.62	0.56	0.45
Fixed Assets Turnover	13.71	11.49	11.84	7.02	5.11
Receivables Turnover (Average Receivables)	3.06	2.19	2.47	2.56	2.41
Inventory Turnover (Average Inventory)	4.75	4.39	5.68	4.86	4.8
Short Term Liquidity
Current Ratio	4.43	4.67	5.74	4.12	4.01
Quick Ratio	3.6	4.09	4.84	3.52	3.49
Operating Cash Flow to Current Liabilities	0.07	0.28	0.13	0.39	0.18
Days Sales Outstanding (Average Receivables)	119.43	166.43	147.9	142.78	151.19
Days Outstanding Inventory (Average Inventory)	76.79	83.18	64.47	75.13	76.07
Average Days Payable Outstanding	96.48	92.98	64.87	69.5	95.13
Cash Conversion Cycle (Average Days)	99.74	156.62	147.5	148.41	132.14
Long Term Solvency
Total Debt/Equity	4.8	1.71	3.45	0.02	1.35
Total Debt / Total Capital	4.58	1.68	3.34	0.02	1.33
LT Debt/Equity	1.75	0.58	-	-	-
Long-Term Debt / Total Capital	1.67	0.57	-	-	-
Total Liabilities / Total Assets	21.58	19.54	16.7	23	23.07
EBIT / Interest Expense	185.06	81.96	20.64	10.79	136.18
EBITDA / Interest Expense	200.58	98.07	26.7	20.29	373.89
(EBITDA - Capex) / Interest Expense	180.1	84.42	6.9	-28.8	5.25
Total Debt / EBITDA	0.27	0.28	0.61	0.01	0.76
Net Debt / EBITDA	-3	-9.71	-10.17	-23.96	-41.14
Total Debt / (EBITDA - Capex)	0.3	0.33	2.36	-0.01	54.28
Net Debt / (EBITDA - Capex)	-3.35	-11.28	-39.33	16.88	-2.93K
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	26.13	-17.2	16.98	3.41	-5.91
Gross Profit, 1 Yr. Growth %	43.11	-13.47	8.87	6.66	-13.46
EBITDA, 1 Yr. Growth %	148.33	-24.12	6.45	-45.39	-30.67
EBITA, 1 Yr. Growth %	167.1	-24.79	-1.49	-62.4	-52.88
EBIT, 1 Yr. Growth %	167.16	-24.92	-1.54	-62.44	-52.88
Earnings From Cont. Operations, 1 Yr. Growth %	94.45	-10.71	33.33	16.25	-23.04
Net Income, 1 Yr. Growth %	94.45	-10.71	33.33	16.25	-23.04
Normalized Net Income, 1 Yr. Growth %	154.67	48.24	-7.6	-49.87	-18.94
Diluted EPS Before Extra, 1 Yr. Growth %	94.45	-10.71	33.33	16.25	-23.04
Accounts Receivable, 1 Yr. Growth %	7.35	22.87	-11.94	13.79	-12.8
Inventory, 1 Yr. Growth %	-6.62	-18.25	8.1	29.08	-24.42
Net Property, Plant and Equip., 1 Yr. Growth %	5.55	-24.49	64	80.54	-5.6
Total Assets, 1 Yr. Growth %	10.59	7.75	9.03	22.07	8.42
Tangible Book Value, 1 Yr. Growth %	13.05	10.58	12.9	12.87	8.22
Common Equity, 1 Yr. Growth %	13.09	10.55	12.88	12.85	8.21
Cash From Operations, 1 Yr. Growth %	-227.65	-10.42	-59.02	402.05	-49.3
Capital Expenditures, 1 Yr. Growth %	-31.99	-48.61	467.07	78.22	-71.49
Levered Free Cash Flow, 1 Yr. Growth %	-231.39	-40.43	-231.04	-179.1	110.8
Unlevered Free Cash Flow, 1 Yr. Growth %	-232.08	-40.32	-224.82	-185.08	110.09
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	19.63	-2.39	-1.58	9.99	-1.36
Gross Profit, 2 Yr. CAGR %	23.66	-2.33	-2.94	7.87	-3.93
EBITDA, 2 Yr. CAGR %	91.39	-3.2	-10.12	-23.76	-38.19
EBITA, 2 Yr. CAGR %	104.96	-4.33	-13.93	-39.14	-57.65
EBIT, 2 Yr. CAGR %	104.9	-4.44	-14.02	-39.19	-57.57
Earnings From Cont. Operations, 2 Yr. CAGR %	175.74	31.77	9.11	24.5	-5.41
Net Income, 2 Yr. CAGR %	175.74	31.77	9.11	24.5	-5.41
Normalized Net Income, 2 Yr. CAGR %	64.79	43.9	4.19	-31.94	-36.26
Diluted EPS Before Extra, 2 Yr. CAGR %	175.74	31.77	9.11	24.5	-5.41
Accounts Receivable, 2 Yr. CAGR %	24.37	14.85	4.02	0.1	-0.39
Inventory, 2 Yr. CAGR %	11	-12.63	-5.99	18.13	-1.22
Net Property, Plant and Equip., 2 Yr. CAGR %	12.99	-10.72	11.28	72.07	32.77
Total Assets, 2 Yr. CAGR %	13.1	9.16	8.39	15.37	15.23
Tangible Book Value, 2 Yr. CAGR %	10.08	11.81	11.74	12.88	10.75
Common Equity, 2 Yr. CAGR %	10.13	11.81	11.71	12.87	10.74
Cash From Operations, 2 Yr. CAGR %	-65.07	128.86	-39.41	43.43	59.54
Capital Expenditures, 2 Yr. CAGR %	-7.24	-40.87	70.72	217.9	-28.72
Levered Free Cash Flow, 2 Yr. CAGR %	10.52	-28.43	-28.67	2.02	31.34
Unlevered Free Cash Flow, 2 Yr. CAGR %	10.5	-28.1	-30.18	3.05	34.08
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	16.42	2.64	3.68	0.06	4.41
Gross Profit, 3 Yr. CAGR %	23.55	0.64	1.27	0.23	0.23
EBITDA, 3 Yr. CAGR %	152.26	11.39	-0.08	-23.88	-25.91
EBITA, 3 Yr. CAGR %	335.23	12.91	-3.4	-34.69	-43.89
EBIT, 3 Yr. CAGR %	335.14	12.79	-3.48	-34.76	-43.83
Earnings From Cont. Operations, 3 Yr. CAGR %	140.6	89.35	32.29	11.44	6.06
Net Income, 3 Yr. CAGR %	140.6	89.35	32.29	11.44	6.06
Normalized Net Income, 3 Yr. CAGR %	64.8	30.22	14.88	-18.36	-27.86
Diluted EPS Before Extra, 3 Yr. CAGR %	140.6	89.35	32.29	11.44	6.06
Accounts Receivable, 3 Yr. CAGR %	8.23	23.87	5.12	7.18	-4.4
Inventory, 3 Yr. CAGR %	3.27	0.24	-6.2	4.49	1.79
Net Property, Plant and Equip., 3 Yr. CAGR %	16.17	-1.22	9.34	30.76	42.46
Total Assets, 3 Yr. CAGR %	8.6	11.29	9.12	12.77	13.12
Tangible Book Value, 3 Yr. CAGR %	8.03	10.25	12.17	12.11	11.46
Common Equity, 3 Yr. CAGR %	7.32	10.27	12.17	12.09	11.45
Cash From Operations, 3 Yr. CAGR %	29.25	-20.59	28.99	22.6	1.41
Capital Expenditures, 3 Yr. CAGR %	36.92	-23.8	25.63	73.18	42.29
Levered Free Cash Flow, 3 Yr. CAGR %	-4.03	-21.91	-24.08	-26.07	31.42
Unlevered Free Cash Flow, 3 Yr. CAGR %	-4.4	-21.82	-24.97	-25.42	30.92
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	14.16	8.14	6.87	5.52	1.64
Gross Profit, 5 Yr. CAGR %	14.52	6.32	6.48	3.47	-0.8
EBITDA, 5 Yr. CAGR %	24.29	13.15	45.17	-4.28	-17.55
EBITA, 5 Yr. CAGR %	25.05	15.39	94.49	-11.82	-30.54
EBIT, 5 Yr. CAGR %	25.04	15.32	94.35	-11.9	-30.53
Earnings From Cont. Operations, 5 Yr. CAGR %	41.1	34.99	75.36	60.11	15.68
Net Income, 5 Yr. CAGR %	41.1	34.99	75.36	60.11	15.68
Normalized Net Income, 5 Yr. CAGR %	16.58	18.28	21.66	-4.11	-9.23
Diluted EPS Before Extra, 5 Yr. CAGR %	41.09	34.99	75.36	60.11	15.68
Accounts Receivable, 5 Yr. CAGR %	5.46	12.42	6.53	13.75	2.88
Inventory, 5 Yr. CAGR %	3.47	-1.63	-0.54	7.04	-4.24
Net Property, Plant and Equip., 5 Yr. CAGR %	12.21	2.6	14.19	23.34	18.17
Total Assets, 5 Yr. CAGR %	4.34	6.6	8.51	12.9	11.52
Tangible Book Value, 5 Yr. CAGR %	6.53	7.54	9.5	11.29	11.6
Common Equity, 5 Yr. CAGR %	5.14	6.65	9.05	11.3	11.59
Cash From Operations, 5 Yr. CAGR %	-33.74	-6.85	29.42	0.6	40.44
Capital Expenditures, 5 Yr. CAGR %	9.21	-10.58	49.57	34.92	0.15
Levered Free Cash Flow, 5 Yr. CAGR %	1.29	-20.41	-21.7	-20.23	-5.39
Unlevered Free Cash Flow, 5 Yr. CAGR %	0.1	-19.9	-22.51	-19.78	-5.36